News
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular ...
In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...
16h
Flow Space on MSNIs This the Secret to Maintaining a Healthy Weight in Menopause?
Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...
The Mounjaro buzz is now distinctly reaching Indian A-listers and wellness-conscious urban adults, sparking conversations about its potential ...
9h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
23h
DPA International on MSNStudy: Lost weight rebounds quickly after stopping weight-loss jabs
Doctors around the world have been hailing "miracle" medications that make weight loss far easier, but new research suggests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results